Product Images Tadalafil

This is a chart displaying the changes in blood pressure (systolic and diastolic) while standing and supine for a drug (Tadalafil) compared with a placebo. The values are measured in mmHg and are presented for different time intervals (in hours).*

This is a table showing the standing and supine systolic blood pressure values (in mmHg) for participants taking Tadalafil and doxazosin or a Placebo and doxazosin combination over a 24-hour period. The time post-dose in hours is also shown.*

This is a graph displaying the concentration of Tadalafil (measured in ug/L) in plasma over a period of 120 hours after receiving a single 20mg dose, a single 5mg dose or a once-daily 5mg dose for 5 consecutive days. The concentration of Tadalafil varies over time and reaches its peak concentration between 12 to 24 hours after administration.*

The text provides a comparison of the change in PSS Total Score between Tadalafil 5 mg and the Placebo treatment. The table shows that the difference is statistically significant with a p-value less than 0.01. The duration of treatment was 4-8 weeks.*

This text provides results from a study comparing tadalafil 5mg with placebo, showing a significant improvement in IPSS total score in the tadalafil group compared to placebo at p<0.01. The duration of the treatment is not specified.*

The text represents the results of a study that compares the effect of Tadalafil 5mg versus a placebo on the change in IPSS total score. The data shows a significant improvement in IPSS total score with Tadalafil 5mg compared to the placebo. However, no information is available about the study design, sample size, or patient characteristics. The text only provides limited information and is not sufficient for a complete understanding of the study's results.*

This is a description of a medication named Tadalafil, which comes in a bottle with 90 tablets. The product number is 6879 and it needs to be stored at 8707 degrees Fahrenheit. The other text appears to be illegible characters.*